Melyssa Aronson1, Steven Gallinger1, Zane Cohen1, Shlomi Cohen2, Rina Dvir3, Ronit Elhasid3, Hagit N Baris4, Revital Kariv5, Harriet Druker6, Helen Chan6, Simon C Ling6,7, Paul Kortan8, Spring Holter1, Kara Semotiuk1, David Malkin6,7, Roula Farah9, Alain Sayad10, Brandie Heald11, Matthew F Kalady11, Lynette S Penney12, Andrea L Rideout12, Mohsin Rashid12, Linda Hasadsri13, Pavel Pichurin13, Douglas Riegert-Johnson14, Brittany Campbell6, Doua Bakry6, Hala Al-Rimawi15, Qasim Kholaif Alharbi16, Musa Alharbi17, Ashraf Shamvil18, Uri Tabori6,7, Carol Durno1,6. 1. Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada. 2. Pediatric Gastro-Enterology Unit, Dana Dwek Children's Hospital, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel. 3. Department of Pediatric Hemato-Oncology, Dana Dwek Children's Hospital, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel. 4. The Genetics Institute, Rambam Health Care Campus, Haifa, Israel, and Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. 5. Department of Gastroenterology and Liver Disease, Tel Aviv Sourasky Medical Centre, Tel Aviv, Israel. 6. Hospital for Sick Children, Toronto, Ontario, Canada. 7. Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada. 8. St Michael's Hospital, Toronto, Ontario, Canada. 9. Saint George Hospital University Medical Center, Beirut, Lebanon. 10. Lebanese American University Medical Centre, Beirut, Lebanon. 11. Cleveland Clinic, Cleveland, Ohio, USA. 12. IWK Health Centre, Halifax, Nova Scotia, Canada. 13. Mayo Clinic, Rochester, Minnesota, USA. 14. Mayo Clinic, Jacksonville, Florida, USA. 15. Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan. 16. Department of Pediatric Hematology/Oncology and Stem Cell Transplant, King Fahad Specialist Hospital, Dammam, Saudi Arabia. 17. King Fahad Medical City, Riyadh, Saudi Arabia. 18. Children Cancer Hospital, Karachi, Pakistan.
Abstract
OBJECTIVES: Hereditary biallelic mismatch repair deficiency (BMMRD) is caused by biallelic mutations in the mismatch repair (MMR) genes and manifests features of neurofibromatosis type 1, gastrointestinal (GI) polyposis, and GI, brain, and hematological cancers. This is the first study to characterize the GI phenotype in BMMRD using both retrospective and prospective surveillance data. METHODS: The International BMMRD Consortium was created to collect information on BMMRD families referred from around the world. All patients had germline biallelic MMR mutations or lack of MMR protein staining in normal and tumor tissue. GI screening data were obtained through medical records with annual updates. RESULTS: Thirty-five individuals from seven countries were identified with BMMRD. GI data were available on 24 of 33 individuals (73%) of screening age, totaling 53 person-years. The youngest age of colonic adenomas was 7, and small bowel adenoma was 11. Eight patients had 19 colorectal adenocarcinomas (CRC; median age 16.7 years, range 8-25), and 11 of 18 (61%) CRC were distal to the splenic flexure. Eleven patients had 15 colorectal surgeries (median 14 years, range 9-25). Four patients had five small bowel adenocarcinomas (SBC; median 18 years, range 11-33). Two CRC and two SBC were detected during surveillance within 6-11 months and 9-16 months, respectively, of last consecutive endoscopy. No patient undergoing surveillance died of a GI malignancy. Familial clustering of GI cancer was observed. CONCLUSIONS: The prevalence and penetrance of GI neoplasia in children with BMMRD is high, with rapid development of carcinoma. Colorectal and small bowel surveillance should commence at ages 3-5 and 8 years, respectively.
OBJECTIVES:Hereditary biallelic mismatch repair deficiency (BMMRD) is caused by biallelic mutations in the mismatch repair (MMR) genes and manifests features of neurofibromatosis type 1, gastrointestinal (GI) polyposis, and GI, brain, and hematological cancers. This is the first study to characterize the GI phenotype in BMMRD using both retrospective and prospective surveillance data. METHODS: The International BMMRD Consortium was created to collect information on BMMRD families referred from around the world. All patients had germline biallelic MMR mutations or lack of MMR protein staining in normal and tumor tissue. GI screening data were obtained through medical records with annual updates. RESULTS: Thirty-five individuals from seven countries were identified with BMMRD. GI data were available on 24 of 33 individuals (73%) of screening age, totaling 53 person-years. The youngest age of colonic adenomas was 7, and small bowel adenoma was 11. Eight patients had 19 colorectal adenocarcinomas (CRC; median age 16.7 years, range 8-25), and 11 of 18 (61%) CRC were distal to the splenic flexure. Eleven patients had 15 colorectal surgeries (median 14 years, range 9-25). Four patients had five small bowel adenocarcinomas (SBC; median 18 years, range 11-33). Two CRC and two SBC were detected during surveillance within 6-11 months and 9-16 months, respectively, of last consecutive endoscopy. No patient undergoing surveillance died of a GI malignancy. Familial clustering of GI cancer was observed. CONCLUSIONS: The prevalence and penetrance of GI neoplasia in children with BMMRD is high, with rapid development of carcinoma. Colorectal and small bowel surveillance should commence at ages 3-5 and 8 years, respectively.
Authors: Olivia Will; Luis G Carvajal-Carmona; Patricia Gorman; Kimberley M Howarth; Angela M Jones; Guadalupe M Polanco-Echeverry; Jo-Anne Chinaleong; Thomas Günther; Andrew Silver; Susan K Clark; Ian Tomlinson Journal: Gastroenterology Date: 2006-11-29 Impact factor: 22.682
Authors: C P Kratz; C M Niemeyer; E Jüttner; M Kartal; A Weninger; A Schmitt-Graeff; U Kontny; M Lauten; S Utzolino; J Rädecke; C Fonatsch; K Wimmer Journal: Leukemia Date: 2007-11-15 Impact factor: 11.528
Authors: Doua Bakry; Melyssa Aronson; Carol Durno; Hala Rimawi; Roula Farah; Qasim Kholaif Alharbi; Musa Alharbi; Ashraf Shamvil; Shay Ben-Shachar; Matthew Mistry; Shlomi Constantini; Rina Dvir; Ibrahim Qaddoumi; Steven Gallinger; Jordan Lerner-Ellis; Aaron Pollett; Derek Stephens; Steve Kelies; Elizabeth Chao; David Malkin; Eric Bouffet; Cynthia Hawkins; Uri Tabori Journal: Eur J Cancer Date: 2014-01-15 Impact factor: 9.162
Authors: M De Rosa; C Fasano; L Panariello; M I Scarano; G Belli; A Iannelli; F Ciciliano; P Izzo Journal: Oncogene Date: 2000-03-23 Impact factor: 9.867
Authors: H F A Vasen; Z Ghorbanoghli; F Bourdeaut; O Cabaret; O Caron; A Duval; N Entz-Werle; Y Goldberg; D Ilencikova; C P Kratz; N Lavoine; J Loeffen; F H Menko; M Muleris; G Sebille; C Colas; B Burkhardt; L Brugieres; K Wimmer Journal: J Med Genet Date: 2014-02-20 Impact factor: 6.318
Authors: Steven Gallinger; Melyssa Aronson; Katayoon Shayan; Elyanne M Ratcliffe; Justin T Gerstle; Patricia C Parkin; Heidi Rothenmund; Marina Croitoru; Ewa Baumann; Peter R Durie; Rosanna Weksberg; Aaron Pollett; Robert H Riddell; Bo Y Ngan; Ernest Cutz; Alain E Lagarde; Helen S L Chan Journal: Gastroenterology Date: 2004-02 Impact factor: 22.682
Authors: Wenche Sjursen; Inga Bjørnevoll; Lars F Engebretsen; Kristine Fjelland; Tore Halvorsen; Helge E Myrvold Journal: Fam Cancer Date: 2008-11-28 Impact factor: 2.375
Authors: A Kerpel; M Yalon; M Soudack; J Chiang; A Gajjar; K E Nichols; Z Patay; S Shrot; C Hoffmann Journal: AJNR Am J Neuroradiol Date: 2020-04-30 Impact factor: 3.825
Authors: Avrum Spira; Mary L Disis; John T Schiller; Eduardo Vilar; Timothy R Rebbeck; Rafael Bejar; Trey Ideker; Janine Arts; Matthew B Yurgelun; Jill P Mesirov; Anjana Rao; Judy Garber; Elizabeth M Jaffee; Scott M Lippman Journal: Proc Natl Acad Sci U S A Date: 2016-09-16 Impact factor: 11.205
Authors: Maribel González-Acosta; Jesús Del Valle; Matilde Navarro; Bryony A Thompson; Sílvia Iglesias; Xavier Sanjuan; María José Paúles; Natàlia Padilla; Anna Fernández; Raquel Cuesta; Àlex Teulé; Guido Plotz; Juan Cadiñanos; Xavier de la Cruz; Francesc Balaguer; Conxi Lázaro; Marta Pineda; Gabriel Capellá Journal: Fam Cancer Date: 2017-10 Impact factor: 2.375
Authors: Carol Durno; Ayse Bahar Ercan; Vanessa Bianchi; Melissa Edwards; Melyssa Aronson; Melissa Galati; Eshetu G Atenafu; Gadi Abebe-Campino; Abeer Al-Battashi; Musa Alharbi; Vahid Fallah Azad; Hagit N Baris; Donald Basel; Raymond Bedgood; Anne Bendel; Shay Ben-Shachar; Deborah T Blumenthal; Maude Blundell; Miriam Bornhorst; Annika Bronsema; Elizabeth Cairney; Sara Rhode; Shani Caspi; Aghiad Chamdin; Stefano Chiaravalli; Shlomi Constantini; Bruce Crooks; Anirban Das; Rina Dvir; Roula Farah; William D Foulkes; Zehavit Frenkel; Bailey Gallinger; Sharon Gardner; David Gass; Mithra Ghalibafian; Catherine Gilpin; Yael Goldberg; Catherine Goudie; Syed Ahmer Hamid; Heather Hampel; Jordan R Hansford; Craig Harlos; Nobuko Hijiya; Saunders Hsu; Junne Kamihara; Rejin Kebudi; Jeffrey Knipstein; Carl Koschmann; Christian Kratz; Valerie Larouche; Alvaro Lassaletta; Scott Lindhorst; Simon C Ling; Michael P Link; Rebecca Loret De Mola; Rebecca Luiten; Michal Lurye; Jamie L Maciaszek; Vanan MagimairajanIssai; Ossama M Maher; Maura Massimino; Rose B McGee; Naureen Mushtaq; Gary Mason; Monica Newmark; Garth Nicholas; Kim E Nichols; Theodore Nicolaides; Enrico Opocher; Michael Osborn; Benjamin Oshrine; Rachel Pearlman; Daniel Pettee; Jan Rapp; Mohsin Rashid; Alyssa Reddy; Lara Reichman; Marc Remke; Gabriel Robbins; Sumita Roy; Magnus Sabel; David Samuel; Isabelle Scheers; Kami Wolfe Schneider; Santanu Sen; Duncan Stearns; David Sumerauer; Carol Swallow; Leslie Taylor; Gregory Thomas; Helen Toledano; Patrick Tomboc; An Van Damme; Ira Winer; Michal Yalon; Lee Yi Yen; Michal Zapotocky; Shayna Zelcer; David S Ziegler; Stefanie Zimmermann; Cynthia Hawkins; David Malkin; Eric Bouffet; Anita Villani; Uri Tabori Journal: J Clin Oncol Date: 2021-05-04 Impact factor: 50.717